3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
11
Head and Neck Neoplasms
5
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Untreated Childhood Anaplastic Astrocytoma
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Salivary Gland Neoplasms
1
Recurrence
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Interventions
Cyclophosphamide
21
Isotretinoin
14
Etoposide
13
Topotecan
12
Irinotecan
12
dinutuximab
10
Temozolomide
10
Magnetic Resonance Spectroscopy
10
Doxorubicin
10
Melphalan
9
sargramostim
8
Vincristine
8
Filgrastim
7
Cisplatin
7
Specimen Handling
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Granulocyte Colony-Stimulating Factor
6
Carboplatin
6
3-Iodobenzylguanidine
6
X-Rays
5
Phantoms, Imaging
5
Busulfan
5
Biopsy
5
fludarabine
4
etoposide phosphate
4
aldesleukin
4
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroblastoma
×
Gefitinib
×
Clear all
No trials found.